Currently, growing evidence shows that CHIP is a new risk factor for coronary artery disease [32], and it is associated with adverse cardiovascular outcomes [33], representing an exciting new frontier for CAD precision medicine [33]. This evidence concerns the gene STUB1 and coronary artery disorder.